Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03854110 |
| Title | Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Geistlich Pharma AG |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hoag Family Cancer Institute | RECRUITING | Newport Beach | California | 92663 | United States | Details |
| University of Kansas Cancer Center | RECRUITING | Fairway | Kansas | 66205 | United States | Details |
| Beth Israel Deaconess Medical Center | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Wake Forest Baptist Health | RECRUITING | Winston-Salem | North Carolina | 27292 | United States | Details |
| Abramson Cancer Center at the University of Pennsylvania | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |